共 50 条
- [1] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trialJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Sherman, M.Mazzaferro, V.Amadori, D.Seitz, J.Moscovici, M.Shan, M.Nadel, A.Voliotis, D.Llovet, J. M.Bruix, J.
- [2] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and prior anti-tumor therapy: A subanalysis from the sharp trialJOURNAL OF HEPATOLOGY, 2008, 48 : S372 - S372Galle, P.Blanc, J.Van Laethem, J-L.Marrero, J.Beaugrand, M.Moscovici, M.Shan, M.Nadel, A.Voliotis, D.Bruix, J.Llovet, J. M.
- [3] Efficacy and safety of sorafenib in patients with advanced HCC and prior anti-tumor therapy: a subanalysis from the SHARP trialONKOLOGIE, 2010, 33 : 84 - +Galle, P.Woerns, M.Blanc, J.Van Laethem, J.Marrero, J.Beaugrand, M.Moscovici, M.Shan, M.Nadel, A.Voliotis, D.Bruix, J.Llovet, J.
- [4] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trialEUROPEAN JOURNAL OF CANCER, 2012, 48 (10) : 1452 - 1465Cheng, Ann-LiiGuan, ZhongzhenChen, ZhendongTsao, Chao-JungQin, ShukuiKim, Jun SukYang, Tsai-ShengTak, Won YoungPan, HongmingYu, ShiyingXu, JianmingFang, FangZou, JessieLentini, GiuseppeVoliotis, DimitrisKang, Yoon-Koo
- [5] EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGEJOURNAL OF HEPATOLOGY, 2009, 50 : S28 - S29Bruix, J.Raoul, J. L.Sherman, M.Shan, M.Lentini, G.Nadel, A.Voliotis, D.Llovet, J. M.
- [6] Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trialEXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 739 - 745Rimassa, LorenzaSantoro, Armando
- [7] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJOURNAL OF HEPATOLOGY, 2012, 57 (04) : 821 - 829Bruix, JordiRaoul, Jean-LucSherman, MorrisMazzaferro, VincenzoBolondi, LuigiCraxi, AntonioGalle, Peter R.Santoro, ArmandoBeaugrand, MichelSangiovanni, AngeloPorta, CamilloGerken, GuidoMarrero, Jorge A.Nadel, AndreaShan, MichaelMoscovici, MariusVoliotis, DimitrisLlovet, Josep M.
- [8] Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinomaCLINICS, 2021, 76 : 1 - 6Marta, Guilherme Naderda Fonseca, Leonardo G.Braghiroli, Maria IgnezMoura, FernandoHoff, Paulo M.Sabbaga, Jorge
- [9] SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMAANNALS OF ONCOLOGY, 2009, 20Sacco, P. C.De Sanctis, R.Quadrini, S.Gori, B.Del, Signore E.Stumbo, L.Tedeschi, M.Falbo, P. T.Fulvi, A.Grassi, P.Sollami, R.Basile, M. L.Di Seri, M.
- [10] Efficacy and safety of sorafenib in patients with alcohol-related hepatocellular carcinoma: A sub-analysis from the SHARP trialJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Craxi, A.Porta, C.Sangiovanni, A.Seitz, J.Moscovici, M.Shan, M.Nadel, A.Voliotis, D.Bruix, J.Llovet, J. M.